What is the debt of Idorsia this year?
Idorsia has a debt level of 985.8 CHF this year.
Idorsia Debt 2024
Idorsia Debt
985.8 CHF
Ticker
IDIA.SW
ISIN
CH0363463438
WKN
A2DTEB
In 2024, Idorsia's total debt was 985.8 CHF, a 0.2% change from the 983.8 CHF total debt recorded in the previous year.
Idorsia Aktienanalyse
What does Idorsia do?
Idorsia Ltd is a biopharmaceutical company that focuses on the discovery, development, and marketing of innovative therapies for patients. The company is headquartered in Switzerland and was founded in 2017 after being spun off from Actelion Ltd. Idorsia was formed by a team of experienced scientists and developers who are known in the industry for their skills and passion for researching new therapies. The company is divided into five main business areas: cardiovascular and respiratory, CNS, immunology, pain, and oncology. Through its research and development activities, Idorsia aims to address medical needs in various areas. The company's innovative therapy approaches have already shown promise and garnered significant attention in the industry. Idorsia receives support from investors and partners. Idorsia's business model is based on an extensive portfolio of already patented and yet-to-be-patented drugs. The company strives to continually optimize and expand its developments within the industry to ultimately treat patients worldwide with its therapies. It collaborates closely with various partners from the biotechnology, pharmaceutical, and other industries to bring products to market and translate scientific knowledge into clinical practice. In the cardiovascular and respiratory field, Idorsia focuses on developing therapies for pulmonary hypertension as well as severe, acute, and chronic cardiovascular diseases. The company's goal is to reduce interventions and interventions for the treatment of these diseases through new treatment options, thus effectively and sustainably improving patients' quality of life. In neurology, Idorsia is involved in research and development of new therapies for disorders of the central nervous system. Here, the company targets the treatment of severe conditions such as epilepsy, sleep disorders, Alzheimer's, and Parkinson's. The research and development activities are carried out in close collaboration with academic research centers and clinics and have already shown success in developing new therapies. In the field of immunology, the company focuses on the development of biological therapies to support the body's immune system in fighting tumors and other severe diseases. Idorsia also focuses on the advancement of personalized medicines tailored to individual patients. In terms of pain, the company focuses on developing therapies that can effectively reduce pain without affecting the patient's perception and quality of life. Idorsia is working on the development of treatment methods that span longer periods and thus serve as an effective alternative to conventional pain therapies. One of the main products introduced by Idorsia is the drug Daridorexant. The drug is a highly selective receptor antagonist developed for the treatment of sleep disorders and other sleep-related conditions. In addition, Idorsia is working on the development of new therapies in the neurology and cardiovascular disease fields. Overall, Idorsia is dedicated to providing patients with valuable and innovative treatment options and, thereby, improving their quality of life. The company relies on scientific research and continuous improvement of its products and services to ensure long-term success in the industry. Idorsia ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Idorsia's Debt Structure
Idorsia's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Idorsia's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Idorsia’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Idorsia’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Idorsia stock
What was the debt of Idorsia compared to the previous year?
The debt of Idorsia has increased by 0.2% compared to the previous year increased.
What are the consequences of high debt for investors in Idorsia?
High debt can pose a risk for investors of Idorsia, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Idorsia?
Low debt means that Idorsia has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Idorsia affect the company?
An increase in debt of Idorsia can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Idorsia affect the company?
A reduction in debt of Idorsia can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Idorsia?
Some factors that can influence the debt of Idorsia include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Idorsia so important for investors?
The debts of Idorsia are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Idorsia take to change the debt?
To change the debt, Idorsia can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Idorsia pay?
Over the past 12 months, Idorsia paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Idorsia is expected to pay a dividend of 0 CHF.
What is the dividend yield of Idorsia?
The current dividend yield of Idorsia is .
When does Idorsia pay dividends?
Idorsia pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Idorsia?
Idorsia paid dividends every year for the past 0 years.
What is the dividend of Idorsia?
For the upcoming 12 months, dividends amounting to 0 CHF are expected. This corresponds to a dividend yield of 0 %.
In which sector is Idorsia located?
Idorsia is assigned to the 'Health' sector.
Wann musste ich die Aktien von Idorsia kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Idorsia from 9/22/2024 amounting to 0 CHF, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.
When did Idorsia pay the last dividend?
The last dividend was paid out on 9/22/2024.
What was the dividend of Idorsia in the year 2023?
In the year 2023, Idorsia distributed 0 CHF as dividends.
In which currency does Idorsia pay out the dividend?
The dividends of Idorsia are distributed in CHF.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Idorsia
Our stock analysis for Idorsia Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Idorsia Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
